Affiliation:
1. Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation
2. Federal State Budgetary Educational Institution of Higher Education “Astrakhan State Medical University” of the Ministry of Healthcare of the Russian Federation
Abstract
A priority in the development of modern healthcare is patient-centered medicine, the main tool of which is the ability to predict the individual response to certain interventions, including the use of medications. This is made possible through the use of knowledge-intensive technologies that provide the detection of certain biomarkers, making it possible to obtain individual information about the patient, in order to personalize the choice and dosing regimen of drugs. The most promising for clinical practice are pharmacogenetic/pharmacogenomic, pharmacoepigenomic and pharmacometabolomic biomarkers.